Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Assets Average for 14 consecutive years, with $1.2 billion as the latest value for Q1 2026.

  • For Q1 2026, Assets Average fell 22.88% year-over-year to $1.2 billion; the TTM value through Mar 2026 reached $1.2 billion, down 22.88%, while the annual FY2025 figure was $1.5 billion, 13.85% up from the prior year.
  • Assets Average hit $1.2 billion in Q1 2026 for Agios Pharmaceuticals, down from $1.3 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.7 billion in Q4 2024 and bottomed at $811.4 million in Q2 2024.
  • Average Assets Average over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2026.
  • Year-over-year, Assets Average crashed 40.68% in 2022 and then surged 86.52% in 2025.
  • Agios Pharmaceuticals' Assets Average stood at $1.2 billion in 2022, then fell by 19.62% to $972.2 million in 2023, then surged by 77.69% to $1.7 billion in 2024, then dropped by 22.35% to $1.3 billion in 2025, then decreased by 7.48% to $1.2 billion in 2026.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.2 billion, $1.3 billion, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.